Procter & Gamble Drops Out Of Somaxon's OTC Silenor Effort
Procter & Gamble Distributing Co. LLC has chosen not to move forward with branded prescription drug company Somaxon Pharmaceuticals Inc. on the development of an over-the-counter version of its insomnia drug...To view the full article, register now.
Already a subscriber? Click here to view full article